客製化抗体市场规模、份额及成长分析（按类型、服务、宿主动物、应用、最终用户和地区划分）－2026-2033年产业预测

全球客製化抗体市场规模预计到 2024 年将达到 1.6369 亿美元，到 2025 年将达到 1.7875 亿美元，到 2033 年将达到 3.6143 亿美元，预测期（2026-2033 年）的复合年增长率为 9.2%。

对客製化治疗和诊断的需求不断增长，正推动全球客製化抗体市场获得大量投资。个人化医疗的趋势凸显了对高特异性抗体试剂的需求，尤其是那些能够区分密切相关的蛋白质亚型的抗体异构体。随着人类蛋白质体大部分结构的解析，许多新兴的研究标靶需要精密的工具来检测细微的结构差异。此外，人们不断追求超越传统化疗的疗效，这持续创造市场机会，抗体药物复合体（ADC）也日益受到关注。 ADC领域的成功案例，尤其是主要企业取得的显着销售收入，进一步凸显了这些公司的投资潜力以及加强产品线的意愿。这推动了抗体领域对定製药物计划和亲和性成熟计划的持续需求。

全球客製化抗体市场驱动因素

精准医疗的日益普及是推动全球客製化抗体市场扩张的主要动力。客製化抗体能够实现针对疾病路径的高度标靶化治疗，在推进自体免疫疾病、感染疾病和癌症等相关研究倡议发挥关键作用。 Abcam 和 Thermo Fisher 等主要企业正在扩大其抗体研发规模，以满足生物製药公司日益增长的临床需求。这一趋势反映出，生物技术和製药行业对客製化抗体解决方案的需求显着增长，旨在提高治疗效果和改善患者预后。

全球客製化抗体市场的限制因素

全球客製化抗体市场的主要限制因素是抗体生产和检测的高成本和漫长流程。学术研究和小规模实验室资金和资源的匮乏阻碍了客製化抗体解决方案的广泛应用。许多新兴企业表示，漫长的交付週期和不断上涨的生产成本是其扩大客製化抗体专案规模的重大障碍。这种情况最终导致客製化抗体在各种研究和治疗应用中的获取管道有限，整体利用率较低，从而影响了市场的成长潜力。

全球客製化抗体市场趋势

全球客製化抗体市场正经历一场重大变革，而自动化和人工智慧的进步正是推动这项变革的动力。人工智慧平台正在增强抗体发现流程，从而显着提高准确性、效率和成本效益。这项变革的特点在于利用电脑建模来设计与目标蛋白具有高亲和力亲和性的抗体。分散式自动化解决方案的出现进一步简化了筛检和合格流程，使得在多个治疗领域快速产生抗体成为可能。这种技术与生物学的融合有望重塑药物研发和诊断应用领域，进而推动市场成长与创新。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术评估
• 监管环境

全球客製化抗体市场规模（按类型和复合年增长率划分）（2026-2033 年）

• 单株抗体
• 多株抗体
• 重组抗体
• 其他客製化抗体形式

全球客製化抗体市场规模（按服务类型划分）及复合年增长率（2026-2033 年）

• 抗体生成
• 抗体生产和纯化
• 碎片化和标籤服务

全球客製化抗体市场规模（按宿主物种划分）及复合年增长率（2026-2033 年）

• 老鼠
• 兔子
• 其他动物/替代宿主

全球客製化抗体市场规模（按应用领域及复合年增长率划分）（2026-2033 年）

• 肿瘤学
• 感染疾病
• 神经生物学
• 干细胞研究
• 免疫学及其他

全球客製化抗体市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 製药和生物技术公司
• 学术和研究机构
• 受託研究机构（CRO）

全球客製化抗体市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Thermo Fisher Scientific Inc.
• Abcam plc
• Bio-Rad Laboratories, Inc.
• GenScript Biotech Corporation
• Creative Biolabs Inc.
• Rockland Immunochemicals Inc.
• Merck Group
• Cell Signaling Technology, Inc.
• BioLegend, Inc.
• Agilent Technologies, Inc.
• ProMab Biotechnologies
• Innovagen AB
• ProteoGenix
• Abnova Corporation
• Precision Antibody
• Sino Biological Inc.
• LifeSpan BioSciences, Inc.
• RayBiotech Inc.
• Rockland
• Labcorp Drug Development

结论与建议

Global Custom Antibody Market size was valued at USD 163.69 Million in 2024 and is poised to grow from USD 178.75 Million in 2025 to USD 361.43 Million by 2033, growing at a CAGR of 9.2% during the forecast period (2026-2033).

The rising demand for custom therapeutic and diagnostic agents is propelling significant investments in the global custom antibody market. The trend toward personalized medicine emphasizes the need for highly specific antibody reagents, particularly those capable of differentiating closely related protein isoforms. With a substantial portion of the human proteome being explored, many new research targets require advanced tools for detecting minor structural variations. Additionally, the growing focus on antibody-drug conjugates (ADCs) continues to create market opportunities, driven by the desire for improved therapeutic indices beyond conventional chemotherapy. Success stories in ADCs, exemplified by substantial sales figures from leading products, further highlight the investment potential and motivation for companies to enhance their pipelines. This fosters ongoing demand for tailored discovery and affinity-maturation projects in the antibody sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Custom Antibody market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Custom Antibody Market Segments Analysis

Global Custom Antibody Market is segmented by Type, Service, Host Animal, Application, End-User and region. Based on Type, the market is segmented into Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom-Antibody Formats. Based on Service, the market is segmented into Antibody Development, Antibody Production & Purification and Fragmentation & Labelling Services. Based on Host Animal, the market is segmented into Mice, Rabbits and Other Animals / Alternative Hosts. Based on Application, the market is segmented into Oncology, Infectious Diseases, Neurobiology, Stem Cell Research and Immunology & Others. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Contract Research Organisations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Custom Antibody Market

The increasing emphasis on precision medicine significantly fuels the expansion of the global custom antibody market. Custom antibodies play a critical role in advancing research initiatives related to autoimmune disorders, infectious diseases, and cancers by facilitating highly targeted approaches to disease pathways. Major companies, including Abcam and Thermo Fisher, are broadening their antibody discovery efforts to cater to the growing clinical needs of biopharmaceutical companies. This trend reflects a broader movement within the biotech and pharmaceutical industries, where there is a notable rise in the adoption of tailored antibody solutions aimed at enhancing therapeutic efficacy and improving patient outcomes.

Restraints in the Global Custom Antibody Market

The Global Custom Antibody market is hindered by several challenges, primarily the high costs and lengthy processes associated with antibody production and testing. Limited funding and resources in academic research and smaller laboratories impede the widespread adoption of custom antibody solutions. Many emerging companies have reported that the combination of extended turnaround times and elevated production costs creates significant barriers to scaling their bespoke antibody programs. This situation ultimately restricts access and reduces the overall utilization of custom antibodies in various research and therapeutic applications, impacting the market's growth potential.

Market Trends of the Global Custom Antibody Market

The Global Custom Antibody market is experiencing significant transformation driven by advancements in automation and artificial intelligence. AI-enabled platforms are enhancing the antibody discovery process, delivering increased accuracy, efficiency, and cost-effectiveness. This shift is characterized by the use of computer modeling to engineer antibodies with high binding affinity to their target proteins. The emergence of decentralized automation solutions is further streamlining the screening and qualification processes, allowing for expedited generation of antibodies across diverse therapeutic areas. This convergence of technology and biology is poised to reshape the landscape of drug development and diagnostic applications, fueling market growth and innovation.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Custom Antibody Market Size by Type & CAGR (2026-2033)

• Market Overview
• Monoclonal Antibodies
• Polyclonal Antibodies
• Recombinant Antibodies
• Other Custom-Antibody Formats

Global Custom Antibody Market Size by Service & CAGR (2026-2033)

• Market Overview
• Antibody Development
• Antibody Production & Purification
• Fragmentation & Labelling Services

Global Custom Antibody Market Size by Host Animal & CAGR (2026-2033)

• Market Overview
• Mice
• Rabbits
• Other Animals / Alternative Hosts

Global Custom Antibody Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oncology
• Infectious Diseases
• Neurobiology
• Stem Cell Research
• Immunology & Others

Global Custom Antibody Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organisations (CROs)

Global Custom Antibody Market Size & CAGR (2026-2033)

• North America (Type, Service, Host Animal, Application, End-User)
  • US
  • Canada
• Europe (Type, Service, Host Animal, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Service, Host Animal, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Service, Host Animal, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Service, Host Animal, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biolabs Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rockland Immunochemicals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLegend, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ProMab Biotechnologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Innovagen AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ProteoGenix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abnova Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision Antibody
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino Biological Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeSpan BioSciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RayBiotech Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rockland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcorp Drug Development
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations